Activation of hepatic stellate cell in Pten null liver injury model

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1755-1536

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Activation of hepatic stellate cell in Pten null liver injury model ; volume:9 ; number:1 ; day:14 ; month:6 ; year:2016 ; pages:1-13 ; date:12.2016
Fibrogenesis & tissue repair ; 9, Heft 1 (14.6.2016), 1-13, 12.2016

Creator: He, Lina

Contributor: Gubbins, James
Peng, Zhechu
Medina, Vivian
Fei, Fan
Asahina, Kinji
Wang, Jiaohong
Kahn, Michael
Rountree, Carl B.
Stiles, Bangyan L.
SpringerLink (Online service)

DOI: 10.1186/s13069-016-0045-1

URN: urn:nbn:de:1111-201606171535

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

He, Lina
Gubbins, James
Peng, Zhechu
Medina, Vivian
Fei, Fan
Asahina, Kinji
Wang, Jiaohong
Kahn, Michael
Rountree, Carl B.
Stiles, Bangyan L.
SpringerLink (Online service)

Other Objects (12)

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Activation of hepatic stellate cell in Pten null liver injury model

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Epigenetic regulation during hepatic stellate cell activation

Mitochondrial uncouplers inhibit hepatic stellate cell activation

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis

Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Related objects

Reset password